Recorded Chinese product: 门冬氨酸钾镁片门冬氨酸钾镁片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

门冬氨酸镁[(CHNO)Mg是一种在国家药监局注册认定的药品。该药品含有门冬氨酸钾和门冬氨酸镁[m、门冬氨酸镁[(chno)mg-1fc39862等成分。

该药品关联的活性成分包括:门冬氨酸钾和门冬氨酸镁[m、门冬氨酸镁[(chno)mg。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司。

您可以探索含有相同成分的其他药品:门冬氨酸钾和门冬氨酸镁[m-837bf283成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 门冬氨酸钾镁片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Manufacturers recorded for this product: 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司.

Explore other medicines containing the same ingredient: 门冬氨酸钾和门冬氨酸镁[m productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 门冬氨酸钾镁片Recorded Chinese product: 门冬氨酸钾镁片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 无水门冬氨酸钾79mg;无水门冬氨酸镁70mgRecorded Chinese specification: 无水门冬氨酸钾79mg;无水门冬氨酸镁70mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 上海旭东海普药业有限公司Chinese legal name: 上海旭东海普药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31022557

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31022557

Manufacturer

Chinese legal name: 上海旭东海普药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31022557

生产企业

上海旭东海普药业有限公司(国产)

适应症

电解质补充药。用于低钾血症、洋地黄中毒引起的心律失常(主要是室性心律失常)以及心肌炎后遗症、充血性心力衰竭、心肌梗塞的辅助治疗。

用法用量

口服:餐后服用,常规用量为每次1-2片,每日3次;根据具体情况剂量可增加至每次3片,每日3次。

不良反应

大剂量可能引致腹泻。

禁忌

高钾血症、急性和慢性肾功能衰竭、Addison氏病、Ⅲ0房室传导阻滞、心源性休克(血压低于90毫米汞柱)。

注意事项

1.肾功能损害、房室传导阻滞者慎用。
2.有电解质紊乱的患者应常规性检测血钾、镁离子浓度。
3.高钾血症患者慎用,应常规性检测血离子浓度。
4.由于胃酸能影响其疗效,因此本品应餐后服用。
5.因本品能够抑制四环素、铁盐和氟化钠的吸收,故服用本品与上述药物时应间隔3小时以上。

贮藏

置密闭容器中,遮光保存。

规格

无水门冬氨酸钾79mg;无水门冬氨酸镁70mg

证据Evidence

  • 批准文号: 国药准字H31022557
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.